The effects of managed care and competition on community-based clinical research

Medical Care

Volumn 44, Issue 7, 2006, Pages 671-679

  Carpenter, William R ^a   Weiner, Bryan J ^a   Kaluzny, Arnold D ^a   Domino, Marisa Elena ^a   Lee, Shoou Yih Daniel ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Cancer; CCOP; Clinical research; Competition; Managed care; Practice based research networks

Indexed keywords

ARTICLE; CLINICAL TRIAL; COMMUNITY CARE; HEALTH CARE ORGANIZATION; HEALTH MAINTENANCE ORGANIZATION; HUMAN; LONGITUDINAL STUDY; METHODOLOGY; NEOPLASM; ORGANIZATION AND MANAGEMENT; PUBLIC RELATIONS; REGRESSION ANALYSIS; UNITED STATES; UNIVERSITY;

CLINICAL TRIALS; COMMUNITY HEALTH SERVICES; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; INTERINSTITUTIONAL RELATIONS; LONGITUDINAL STUDIES; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASMS; REGRESSION ANALYSIS; UNITED STATES; UNIVERSITIES;

EID: 33746679387     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlr.0000220269.65196.72     Document Type: Article

References (47)

1. Zerhouni E. The NIH roadmap. Science. 2003;302:63-72.
2. Institute of Medicine. Ensuring Quality Cancer Care. Washington DC: National Academy Press; 1999.
3. Warnecke R, Johnson T, Kaluzny A, et al. The community clinical oncology program: its effect on clinical practice. Jt Comm J Qual Improv. 1995;21:336-339.
4. Laliberte L, Fennell ML, Papandonatos G. The relationship of membership in research networks to compliance with treatment guidelines for early-stage breast cancer. Med Care. 2005;43:471-479.
5. Moulton G. Community clinical oncology program celebrates 20 years of trials and a few tribulations. J Natl Cancer Inst. 2003;95:1822-1824.
6. Kaluzny A, Warnecke R. Managing a Health Care Alliance: Improving Community Cancer Care. San Francisco: Jossey-Bass; 1996.
7. Cobau C. Clinical trials in the community. Cancer. 1994;74:2694-2700.
8. Baker L. Managed care and technology adoption in health care: evidence from magnetic resonance imaging. Journal of Health Economics. 2001a; 20:395-421.
9. Miller R, Luft H. HMO plan performance update: an analysis of the literature, 1997-2001. Health Aff (Millwood). 2002;21:63-86.
10. Miller R, Luft H. Does managed care lead to a better or worse quality of care? Health Aff (Millwood). 1997;16:25.
11. Phillips K, Fernyak S, Potosky A, et al. Use of preventive services by managed care enrollees: an updated perspective. Health Aff (Milhvood). 2000;19:102-116.
12. Phillips K, Haas J, Liang S, et al. Are gatekeeper requirements associated with cancer screening utilization? Health Serv Res. 2004;39:153-178.
13. Riley G, Potosky A, Klabunde C, et al. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA. 1999;281:720-726.
14. Potosky A, Merrill R, Riley G, et al. Breast cancer survival and treatment in health maintenance organization and fee-for-service settings. J Natl Cancer Inst. 1997;89:1683-1691.
15. Lee-Feldstein A, Feldstein P, Buchmueller T, et al. The relationship of HMOs, health insurance, and delivery systems to breast cancer out-comes. Med Care. 2000;38:705-718.
16. Lee-Feldstein A, Anton-Culver H, Feldstein P. Treatment differences and other prognostic factors related to breast cancer survival. Delivery systems and medical outcomes. JAMA. 1994;271:1163-1168.
17. Gansler T, Eyre H. From the editors: encouraging participation in cancer clinical trials, one step at a time. CA Cancer J Clin. 2000;50:340-341.
18. Kovach J. Clinical cancer research in a managed-care environment. Cancer Invest. 1998;16:350-352.
19. Coltman C. Clinical trials: a congressional focus of need. Oncologist. 1997;2:VII-VIII.
20. Jenks S. Does managed care jeopardize cancer research? J Natl Cancer Inst. 1995;87:1102-1106.
21. Purdy S, Finkelstein J, Fletcher R, et al. Patient participation in research in the managed care environment: key perceptions of members in an HMO. J Gen Intern Med. 2000;15:492-495.
22. Wade J, White R. ACCCC's 1997 membership survey. Oncology Issues. 1998;Jan/Feb:26-28.
23. Klabunde C, Springer B, Butler B, et al. Factors influencing enrollment in clinical trials for cancer treatment. South Med J. 1999;92:1189-1193.
24. Lara P Jr, Higdon R, Lim N, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001;19:1728-1733.
25. Gross CP, Krumholz HM. Impact of managed care on cancer trial enrollment. J Clin Oncol. 2005;23:3811-3818.
26. Baker L. Association of managed care market share and health expenditures for fee-for-service Medicare patients. JAMA. 1999;281:432-437.
27. GHAA. National Directory of HMOs (years 1991-1994). Washington DC: GHAA; 1992-1995.
28. Competitive Edge Database (years 1995-2000). Excelsior MN: Inter-study Publications; 1996-2001.
29. American Hospital Association Annual Survey of Hospitals. Chicago: American Hospital Association; 1992-2003.
30. ARF. US Department of Health and Human Services, Health Resources and Services Administration. Rockville, MD: Bureau of Health Professions; 1992-2003.
31. US Census Bureau. CPS- Current Population Survey. March Supplement 1991-2002.
32. Simone JV, Lyons J. The evolution of cancer care for children and adults. J Clin Oncol. 1998; 16:2904-2905.
33. Klabunde C, Kaluzny A, Ford L. Community clinical oncology program participation in the breast cancer prevention trial: factors affecting accrual. Cancer Epidemiol Biomarkers Prev. 1995;4:783-789.
34. Wooldridge J. A simple specification test for the predictive ability of transformation models. Review of Economics and Statistics. 1994;76:59-65.
35. Kongstvedt P. Essentials of Managed Health Care, 4th ed. Gaithersburg, MD: Aspen; 2003.
36. Clement J, Grazier K. HMO penetration: has it hurt public hospitals'? J Health Care Finance. 2001;28:25-38.
37. Wholey D, Feldman R, Christianson J. The effect of market structure on HMO premiums. Journal of Health Economics. 1995;14:81-105.
38. Baker L. Measuring competition in health care markets. Health Serv Res. 2001b;36:223-251.
39. Wooldridge J. Introductory Econometrics. South-Western College Publishing; 2000.
40. Hausman J. Specification tests in econometrics. Econometrica. 1978;46: 1251-1271.
41. Stata Base Reference Manual for Stata Statistical Software: Release 8.3. College Station, TX: Stata Corp; 2003.
42. D'Aunno D, Alexander J. In: Mick S, Wyttenbach M, eds. Advances in Health Care Organization Theory. San Francisco: Jossey-Bass; 2003.
43. Burns L, Bazzoli G, Dynan L, et al. Managed care, market stages, and integrated delivery systems: is there a relationship? Health Aff (Millwood). 1997;16:204-218.
44. Coile R. The Five Stages of Managed Care: Strategies for Providers, HMOs, and Suppliers. Chicago: Health Administration Press; 1997.
45. Kaluzny A, Ricketts T. Partners for the Dance: Forming Strategic Alliances in Health Care. Chicago: Health Administration Press; 1995.
46. Reschovsky J, Kemper P, Tu H, et al. Do HMOs make a difference? Comparing access, service use and satisfaction between consumers in HMOs and non-HMOs. Issue Brief (28): Center for Studying Health System Change. 2000:1-8.
47. Mays GP, Claxton G, White J. Managed care rebound? Recent changes in health plans' cost containment strategies. Health Affairs (Millwood). 2004;Suppl Web Exclusives:W4-427-436.